Neoadjuvant stereotactic body radiotherapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer.

Niu, N; Cao, S; Chen, GL; Xue, JQ; Zhang, Y; Xu, YQ; Yin, JQ; Liu, C; Jiang, XF; Tang, MY; Xu, QS; Jia, MX; Zhang, X; Zhang, ZY; Li, HJ; Li, AL; Liu, CG

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索